These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35538309)

  • 1. Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading.
    Huang W; Bao Y; Luo X; Yao L; Yuan L
    Endocrine; 2022 Jun; 77(1):188-198. PubMed ID: 35538309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic characteristics and survival outcomes in neuroendocrine carcinoma of the ovary.
    Zhu Y; Meng F; Fang H; Zhang Z; Wang L; Zheng W
    Int J Gynecol Cancer; 2020 Feb; 30(2):207-212. PubMed ID: 31796530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine neoplasms of the ovary: a review of 63 cases.
    Flores Legarreta A; Saab R; Gonzales NR; Chisholm GB; Westin SN; Hillman RT; Frumovitz M
    Int J Gynecol Cancer; 2024 Apr; 34(4):566-573. PubMed ID: 38290783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case series of ovarian neuroendocrine carcinoma: overview of clinicopathological features.
    Feng BJ; Li TH; Li YH; Feng JX; Zhang J; Ma JY; Wang YW; Lu SS
    BMC Womens Health; 2023 Nov; 23(1):595. PubMed ID: 37953251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary neuroendocrine tumors of the ovary: Management and outcomes.
    Pang L; Guo Z
    Cancer Med; 2021 Dec; 10(23):8558-8569. PubMed ID: 34773393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance for colorectal carcinoid tumors based on the 8th edition TNM staging system.
    Gong P; Chen C; Wang Z; Zhang X; Hu W; Hu Z; Li X
    Cancer Med; 2020 Nov; 9(21):7979-7987. PubMed ID: 32897004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features, incidence, and survival trends of gynecologic neuroendocrine tumors: a SEER database analysis.
    Gibbs J; Mei S; Economos K; Lee YC; Kanis MJ
    Am J Obstet Gynecol; 2019 Jul; 221(1):53.e1-53.e6. PubMed ID: 30849352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.
    Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Kato T; Takahashi K; Ariyoshi K; Suzuki K; Arimoto T; Matsumoto Y; Nakai H; Inoue T; Yokoyama M; Kawabata T; Kodama S; Miyamoto T; Takano M; Yaegashi N
    Gynecol Oncol; 2019 Dec; 155(3):444-451. PubMed ID: 31635755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of lung neuroendocrine carcinoma with carcinoid morphology.
    Inafuku K; Yokose T; Ito H; Eriguchi D; Samejima J; Nagashima T; Nakayama H; Suzuki M; Yamada K; Masuda M
    Diagn Pathol; 2019 Sep; 14(1):104. PubMed ID: 31511024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms.
    Yi Z; Liu R; Hu J; He T; Wang Z; Li Y; Zu X
    Clin Genitourin Cancer; 2021 Apr; 19(2):155-161. PubMed ID: 33288452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of histological subtype on long-term outcomes of neuroendocrine carcinoma of the breast.
    Cloyd JM; Yang RL; Allison KH; Norton JA; Hernandez-Boussard T; Wapnir IL
    Breast Cancer Res Treat; 2014 Dec; 148(3):637-44. PubMed ID: 25399232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
    Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
    Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung neuroendocrine neoplasms: a single centre surgical series and analysis of staging.
    Davies RA; Alam NZ; Wright GM
    ANZ J Surg; 2023 Jun; 93(6):1543-1550. PubMed ID: 37106553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database.
    Zhai H; Li D; Feng Q; Qian X; Li L; Yao J
    Int J Surg; 2019 Jun; 66():103-109. PubMed ID: 30872175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
    Xu B; Chu Y; Hu Q; Song Q
    Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 18. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic analysis of colon and rectal neuroendocrine neoplasm in different stages].
    Huang YT; Jia R; Xu Q; Ji SJ; Cui HT; Xu JM
    Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):146-151. PubMed ID: 30862146
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
    Guo H; Chen H; Wang W; Chen L
    Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.